Price-sensitive information on issuers of securities up to 08/02/2020

PHARMA MAR, S.A.

from 01/07/1988 to 01/11/2024

The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish

• • 22/01/2020
  • 08:21
  • PHARMA MAR, S.A.
  • R&D: new licenses, patents and registered trademarks
  • Pharma Mar announces fulfillment of the condition consisting on the authorization by the United States antitrust authorities to the exclusive license agreement entered with Jazz Pharmaceuticals.
  • Register number: 286053
  • • Related with 284941 of 19/12/2019 (13:58)
• • 21/01/2020
  • 17:16
  • PHARMA MAR, S.A.
  • Composition of other management and supervisory bodies
  • The Company informs of the appointment of Mr. Carlos Pazos Campos as a member of the Appointments and Compensation Committee.
  • Register number: 286047
• • 08/01/2020
  • 17:50
  • PHARMA MAR, S.A.
  • Liquidity contracts and specialists
  • The Company reports details of the operations of the Liquidity Agreement between 01/10/2019 and 31/12/2019
  • Register number: 285701
  • • Related with 266399 of 04/06/2018 (17:39)
• • 19/12/2019
  • 13:58
  • PHARMA MAR, S.A.
  • R&D: new licenses, patents and registered trademarks. - Announcements of public presentations and meetings
  • Pharma Mar and Jazz Pharmaceuticals have entered into an exclusive license agreement to commercialize lurbinectedin in the United States.
  • Register number: 284941
  • • Related with 286053 of 22/01/2020 (08:21)
• • 17/12/2019
  • 08:10
  • PHARMA MAR, S.A.
  • R&D: new licenses, patents and registered trademarks
  • Phama Mar submits New Drug Application for lurbinectedin under accelerated approval in small cell lung cancer in the USA.
  • Register number: 284566
  • • Related with 281246 of 19/08/2019 (08:27)
• • 23/10/2019
  • 18:49
  • PHARMA MAR, S.A.
  • Composition of other management and supervisory bodies
  • The Company reports the appointment of the Chairman of the Audit Committee.
  • Register number: 282799
• • 23/10/2019
  • 18:32
  • PHARMA MAR, S.A.
  • Information on P&L
  • The Company sends press release regarding the third quarter 2019 results.
  • Register number: 282796
• • 23/10/2019
  • 18:23
  • PHARMA MAR, S.A.
  • Interim financial information
  • La sociedad remite información sobre los resultados del tercer trimestre de 2019
  • Register number: 282795
• • 03/10/2019
  • 17:51
  • PHARMA MAR, S.A.
  • Liquidity contracts and specialists
  • The Company reports details of the operations of the Liquidity Agreement between 01/07/2019 and 30/09/2019
  • Register number: 282269
  • • Related with 266399 of 04/06/2018 (17:39)
• • 26/08/2019
  • 08:29
  • PHARMA MAR, S.A.
  • R&D: new licenses, patents and registered trademarks
  • Pharma Mar and Janssen have entered into a new licensing agreement for Yondelis in US and a master product transfer agreement regarding Yondelis rights in the rest of territories licensed to Janssen.
  • Register number: 281299